Shanmuga Hos.

Who are the top shareholders of the Shanmuga Hos.?

The top shareholders of Shanmuga Hos. include Panneerselvam Prabu Sankar with 18.01%, and individual investors who own 24.48%. Notably, there are no pledged promoter holdings, and the largest public shareholder is Black Fox Financial Private Limited with 1.41%.

The top shareholders of Shanmuga Hos. primarily consist of promoters, with Panneerselvam Prabu Sankar holding the largest stake at 18.01%. There are no pledged promoter holdings, indicating a strong commitment from the promoters. In terms of institutional investors, there is one Foreign Institutional Investor (FII) holding a small stake of 0.19%. The highest public shareholder is Black Fox Financial Private Limited, which holds 1.41%. Additionally, individual investors collectively own 24.48% of the company.

When is the next results date for Shanmuga Hos.?

No Upcoming Board Meetings

Has Shanmuga Hos. declared dividend?

No Dividend History Available

Who are the peers of the Shanmuga Hos.?

Peers of Shanmuga Hos. include Lotus Eye Hospital, Fortis Malar, KK Shah Hospital, Global Longlife, Soni Medicare, Sangani Hospital, Aatmaj Health, Nidan Laboratories, and Vaidya Sane. Shanmuga Hos. has excellent management risk and capital structure, but below-average growth, while Soni Medicare leads in 1-year returns at 116.64%.

Peers: The peers of Shanmuga Hos. are Lotus Eye Hospit, Fortis Malar, KK Shah Hospital, Global Longlife, Soni Medicare, Sangani Hospital, Aatmaj Health, Nidan Laborator., and Vaidya Sane.<BR><BR>Quality Snapshot: Excellent management risk is observed at Shanmuga Hos., while Average management risk is found at Lotus Eye Hospit and Global Longlife, and the rest have Below Average management risk. Growth is rated as Below Average for Shanmuga Hos., Lotus Eye Hospit, Fortis Malar, KK Shah Hospital, Global Longlife, Soni Medicare, Sangani Hospital, Nidan Laborator., and Vaidya Sane, while Aatmaj Health has Good growth. Capital Structure is Excellent at Shanmuga Hos. and Good at Lotus Eye Hospit, KK Shah Hospital, Aatmaj Health, Sangani Hospital, and Vaidya Sane, with the rest rated as Below Average.<BR><BR>Return Snapshot: Soni Medicare has the highest 1-year return at 116.64%, while KK Shah Hospital has the lowest at -6.52%, with Shanmuga Hos. not reporting a 1-year return. Additionally, Global Longlife and Nidan Laborator. have negative six-month returns.

What does Shanmuga Hos. do?

Shanmuga Hospital Ltd is a micro-cap company in the hospital industry, incorporated in 2020 and converted to a public company. It currently reports no sales or profits, with a market cap of INR 63 Cr and key metrics indicating a P/E of 15.00 and a dividend yield of 0.00%.

Overview:<BR>Shanmuga Hospital Ltd operates in the hospital industry and is categorized as a micro-cap company.<BR><BR>History:<BR>Shanmuga Hospital Ltd was originally incorporated as a Private Limited Company on June 26, 2020, under the name "Shanmuga Hospital Private Limited." It later converted to a Public Company, resulting in a name change to "Shanmuga Hospital Limited." There is no sales or profit data reported for any quarter.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: N/A<BR>Market-cap value: INR 63 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 15.00<BR>Industry P/E: 59<BR>Dividend Yield: 0.00%<BR>Debt-Equity: 0.00<BR>Return on Equity: 0.00%<BR>Price-to-Book: 0.00<BR><BR>Contact Details:<BR>Registrar Address: Not available.

How big is Shanmuga Hos.?

As of 24th July, Shanmuga Hospital Ltd has a market capitalization of 65.00 Cr, classified as a Micro Cap. There is no valid data available for recent financial metrics such as Net Sales, Net Profit, Shareholder's Funds, or Total Assets.

As of 24th July, <BR><BR>Market Cap: Shanmuga Hospital Ltd has a market capitalization of 65.00 Cr, classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: There is no valid data available for Net Sales or Net Profit for the latest 4 quarters.<BR><BR>Balance Sheet Snapshot: There is no valid data available for the latest annual period regarding Shareholder's Funds or Total Assets.

How has been the historical performance of Shanmuga Hos.?

Shanmuga Hos. has shown steady growth in net sales, increasing from 39.34 Cr in Mar'23 to 47.85 Cr in Mar'25, but experienced a decline in operating profit and net income, with profit after tax falling to 4.21 Cr in Mar'25. Despite rising total assets to 52.78 Cr, cash flow from operating activities turned negative at -12.00 Cr in Mar'25.

Answer:<BR>The historical performance of Shanmuga Hos. shows a steady increase in net sales over the past three years, rising from 39.34 Cr in Mar'23 to 43.04 Cr in Mar'24, and reaching 47.85 Cr in Mar'25. The total operating income mirrored this trend, with a consistent increase to 47.85 Cr in Mar'25. However, the operating profit (PBDIT) has seen a slight decline from 8.95 Cr in Mar'24 to 8.47 Cr in Mar'25, despite an increase in other income. Profit before tax also decreased from 7.02 Cr in Mar'24 to 5.69 Cr in Mar'25, leading to a profit after tax of 4.21 Cr in Mar'25, down from 5.25 Cr in Mar'24. The earnings per share (EPS) reflected this decline, dropping to 3.09 in Mar'25 from 5.36 in Mar'24. On the balance sheet, total assets increased significantly from 33.92 Cr in Mar'24 to 52.78 Cr in Mar'25, driven by a rise in cash and bank balances and total reserves. Total liabilities also rose, but at a slower pace, resulting in a stronger equity position with shareholder's funds increasing to 39.70 Cr in Mar'25. Cash flow from operating activities turned negative in Mar'25 at -12.00 Cr, contrasting with a positive cash flow of 9.00 Cr in Mar'24, while financing activities provided a net inflow of 16.00 Cr in Mar'25.<BR><BR>Breakdown:<BR>Shanmuga Hos. has demonstrated a positive trend in net sales, which increased from 39.34 Cr in Mar'23 to 47.85 Cr in Mar'25. Despite this growth in revenue, the operating profit (PBDIT) has slightly declined, indicating rising costs, particularly in employee expenses and other expenses, which totaled 39.61 Cr in Mar'25. The profit before tax decreased to 5.69 Cr in Mar'25, resulting in a profit after tax of 4.21 Cr. The company's equity capital and reserves have significantly improved, with total reserves reaching 26.09 Cr in Mar'25, contributing to a total shareholder's fund of 39.70 Cr. The total assets have also increased to 52.78 Cr, primarily due to higher cash and bank balances, while total liabilities rose to 7.61 Cr. However, cash flow from operating activities has turned negative, highlighting potential liquidity challenges despite a positive cash flow from financing activities.

Is Shanmuga Hos. overvalued or undervalued?

As of December 4, 2025, Shanmuga Hospitals is considered very expensive and overvalued with a PE ratio of 15.62, despite outperforming the Sensex with an 8.66% return, while its valuation remains elevated compared to peers like Max Healthcare and Apollo Hospitals.

As of 4 December 2025, the valuation grade for Shanmuga Hospitals has moved from expensive to very expensive, indicating a significant shift in its perceived value. The company is currently considered overvalued. Key ratios include a PE ratio of 15.62, an EV to EBITDA of 8.71, and a ROCE of 12.75%. <BR><BR>In comparison to its peers, Shanmuga Hospitals' PE ratio is substantially lower than that of Max Healthcare, which stands at 74.46, and Apollo Hospitals at 61.81, both of which are categorized as very expensive and attractive, respectively. Despite this, the company's valuation remains elevated relative to its industry peers. Notably, Shanmuga Hospitals has outperformed the Sensex over the past month, with a stock return of 8.66% compared to the Sensex's 2.16%, reinforcing the notion of its current overvaluation.

Why is Shanmuga Hospital Ltd falling/rising?

As of 11-Apr, Shanmuga Hospital Ltd's stock price is stable at 41.39, with a recent weekly gain of +14.97%. Despite strong short-term performance, the stock has a year-to-date decline of -12.86% and shows signs of erratic trading and reduced investor participation, indicating a cautious outlook.

As of 11-Apr, Shanmuga Hospital Ltd's stock price is currently stable at 41.39, showing no change (0.00%). However, the stock has recently experienced a significant rise over the past week, with a return of +14.97%, which is notably higher than the Sensex's increase of +5.77% during the same period. Over the past month, the stock has also outperformed the benchmark, rising by +11.71% while the Sensex has fallen by -0.84%.<BR><BR>Despite these positive short-term trends, the stock has a year-to-date decline of -12.86%, which is worse than the Sensex's decline of -9.00%. In the longer term, the stock has performed well over the past year, with a return of +29.34%, compared to the Sensex's +5.01%. <BR><BR>Today's performance indicates that the stock has underperformed its sector by -0.57%, and there are signs of erratic trading, as it did not trade on one day out of the last 20 days. Additionally, there has been a significant drop in investor participation, with delivery volume on 09 April falling by -77.27% compared to the 5-day average. While the stock is trading above its 5-day, 20-day, and 50-day moving averages, it remains below its 100-day and 200-day moving averages, suggesting mixed signals regarding its price momentum.<BR><BR>Overall, while Shanmuga Hospital Ltd has shown strong short-term gains, the decline in investor participation and the erratic trading pattern may contribute to a cautious outlook for the stock's price stability moving forward.

Which are the latest news on Shanmuga Hos.?